Advanced search
Publication Cover
International Journal of Neuroscience Volume 125, 2015 - Issue 11
Submit an article Journal homepage
321
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort

R. A. AlroughaniDivision of Neurology, Amiri Hospital, Sharq, Kuwait;Neurology Clinic, Dasman Diabetes Institute, Dasman, KuwaitCorrespondence[email protected]
,
S. AkhtarDepartment of Community Medicine & Behavioural Sciences, Faculty of Medicine, Kuwait University, Jabriya, Kuwait
,
S. F. AhmedDepartment of Neurology, Ibn Sina Hospital, Safat, Kuwait;Department of Neurology and Psychiatry, Minia University, Minia, Egypt
&
J. Y. Al-HashelDepartment of Neurology, Ibn Sina Hospital, Safat, Kuwait;Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait
Pages 831-837 | Received 05 Aug 2014, Accepted 10 Oct 2014, Published online: 11 Nov 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, Abdulrahman AlTahan, Issa Alsharoqi, Saeed A Bohlega, Abdulkader Daif, Dirk Deleu, Jihad Inshasi, Rana Karabudak, Mohammed A. Sahraian, Karim Taha, Bassem I. Yammout & Magd Zakaria. (2017) Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?. International Journal of Neuroscience 127:10, pages 944-951.
Read now

Articles from other publishers (15)

Gianmarco Abbadessa, Marta Ponzano, Floriana Bile, Giuseppina Miele, Alessio Signori, Simone Cepparulo, Maddalena Sparaco, Elisabetta Signoriello, Giorgia Teresa Maniscalco, Roberta Lanzillo, Vincenzo Brescia Morra, Giacomo Lus, Maria Pia Sormani, Luigi Lavorgna & Simona Bonavita. (2023) Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 75, pages 104731.
Crossref
Eiman M Mohammed. (2023) Circular RNA in Multiple Sclerosis: Pathogenicity and Potential Biomarker Development: A Systematic Review. Epigenetics Insights 16.
Crossref
Pauline E. M. van Schaik, Inge S. Zuhorn & Wia Baron. (2022) Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery. International Journal of Molecular Sciences 23:15, pages 8418.
Crossref
Melinda Magyari & Nils Koch-Henriksen. (2022) Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:7, pages 716-722.
Crossref
Daniele Belvisi, Marco Canevelli, Viola Baione, Maria Chiara Buscarinu, Giulia Pellicciari, Roberta Fantozzi, Armando Creta, Gianluca Cecchi, Gaia Cola, Carolina Gabri Nicoletti, Antonio Cortese, Laura De Giglio, Matteo Tartaglia, Sebastiano Giuseppe Crisafulli, Giuseppe Bruno, Elisabetta Ferraro, Girolama Alessandra Marfia, Diego Centonze, Marco Salvetti & Antonella Conte. (2021) Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation. Multiple Sclerosis Journal 27:12, pages 1939-1947.
Crossref
Fatma Kara, Mehmet Fatih Göl & Cavit Boz. (2021) Determinants of disability development in patients with multiple sclerosis. Arquivos de Neuro-Psiquiatria 79:6, pages 489-496.
Crossref
Yao Zhang, Yan Xu, Tao Xu, Hexiang Yin, Yicheng Zhu, Bin Peng & Liying Cui. (2020) Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study. Multiple Sclerosis and Related Disorders 46, pages 102461.
Crossref
Xin Tian, Chaoyang Chen, Lingyun Ma, Ran Wei, Min Li, Xiaoqing Wang, Ye Wu, Ying Zhou & Yimin Cui. (2020) Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Journal of Neuroimmunology 347, pages 577317.
Crossref
Dylan A. Galloway, Elizabeth Gowing, Solmaz Setayeshgar & Rashmi Kothary. (2019) Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Glia 68:5, pages 859-877.
Crossref
Ting Yang, Xin Tian, Chao‐Yang Chen, Ling‐Yun Ma, Shuang Zhou, Min Li, Ye Wu, Ying Zhou & Yi‐Min Cui. (2020) The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis. British Journal of Clinical Pharmacology 86:4, pages 637-645.
Crossref
Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand’Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Raymond Hupperts, Cavit Boz, Jeannette Lechner-Scott, Eugenio Pucci, Roberto Bergamaschi, Vincent Van Pesch, Serkan Ozakbas, Franco Granella, Recai Turkoglu, Gerardo Iuliano, Daniele Spitaleri, Pamela McCombe, Claudio Solaro, Mark Slee, Radek Ampapa, Aysun Soysal, Thor Petersen, Jose Luis Sanchez-Menoyo, Freek Verheul, Julie Prevost, Youssef Sidhom, Bart Van Wijmeersch, Steve Vucic, Edgardo Cristiano, Maria Laura Saladino, Norma Deri, Michael Barnett, Javier Olascoaga, Fraser Moore, Olga Skibina, Orla Gray, Yara Fragoso, Bassem Yamout, Cameron Shaw, Bhim Singhal, Neil Shuey, Suzanne Hodgkinson, Ayse Altintas, Talal Al-Harbi, Tunde Csepany, Bruce Taylor, Jordana Hughes, Jae-Kwan Jun, Anneke van der Walt, Tim Spelman, Helmut Butzkueven & Tomas Kalincik. (2019) Risk of secondary progressive multiple sclerosis: A longitudinal study. Multiple Sclerosis Journal 26:1, pages 79-90.
Crossref
V.A. Castañeda-Moreno, U. De la Cruz-Mosso, N. Torres-Carrillo, M.A. Macías-Islas, O. Padilla-De la Torre, M.A. Mireles-Ramírez, O. González-Pérez, J.L. Ruiz-Sandoval, M. Huerta, X. Trujillo, D. Ortuño-Sahagún & J.F. Muñoz-Valle. (2018) MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. Journal of Neuroimmunology 320, pages 117-124.
Crossref
John W. Rose, Gavin Giovannoni, Heinz Wiendl, Ralf Gold, Eva Havrdov?Ludwig Kappos, Krzysztof W. Selmaj, Jun Zhao, Katherine Riester, L. Claire Tsao & Steven J. Greenberg. (2017) Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 17, pages 32-40.
Crossref
Georgios Tsivgoulis, Aristeidis H. Katsanos, Dimitris Mavridis, Nikolaos Grigoriadis, Efthymios Dardiotis, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Theodoros Karapanayiotides, Constantinos Kilidireas, Georgios M. Hadjigeorgiou & Konstantinos Voumvourakis. (2016) The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials. PLOS ONE 11:9, pages e0163296.
Crossref
Eiman M.A. Mohammed. (2016) Multiple sclerosis is prominent in the Gulf states: Review. Pathogenesis 3:2, pages 19-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.